Navigation Links
Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
Date:4/18/2013

JERUSALEM, April 18, 2013 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that its abstract, titled "Oral insulin may be effective in lowering hepatic insulin resistance and inflammation in patients with type 2 diabetes," has been selected for poster presentation at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria. The poster will be presented by Dr. Ehud Arbit , Oramed's Director of Research & Development on Friday, April 19th, during poster session #1: "Insulin Resistance: Various Aspects."  

The 5th Congress on Prediabetes and the Metabolic Syndrome will be addressing the markedly increased risk of diabetes and cardiovascular disease by exploring the latest issues and presenting pioneering research from world leaders and specialists in the field.

For more information on the Congress please visit their website, here.

About Oramed Pharmaceuticals  

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines currently delivered via injection. Established in 2006, Oramed's technology is based on over 30 years of research by top research scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801) currently approaching Phase 2 clinical trials under U.S. IND, and with its oral exenatide capsule (ORMD-0901; a GLP-1 analog), currently approaching Phase 2a trials. The company's corporate and R&D headquarters are based in Jerusalem.


'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
2. Oramed Submits New IND Application for Oral Insulin Trial in the US
3. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
4. Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin
5. Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market
6. Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th
7. Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials
8. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
9. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
10. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
11. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... has announced the addition of the ... to their offering.      (Logo: ... been broadly classified into wide categories based ... for the treatment of different gynecological conditions ...
(Date:9/19/2014)... 2014  4WEB Medical announces the formal launch of ... osteotomy implants on the market today at this ... in Chicago .  The Osteotomy Truss ... needs with 74 size options included in one versatile ... only 15 to 18 implant sizes, which limited a ...
(Date:9/19/2014)... 2014 UBM Medica US announces that  ... to help oncologists and other clinicians gain a better ... of targeted therapies and immunotherapies, discusses some of the ... Every September, Blood Cancer Awareness Month ... about blood cancers—helping to increase survival rates and improve ...
Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 34WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4
... Cellceutix Corporation (Pink Sheets: CTIX ) today ... Agreement (CDA) pertaining to its anti-cancer drug, Kevetrin™, with ... Cellceutix CEO, Leo Ehrlich, commented, "It,s relatively uncommon ... a compound before clinical trials are underway.  The process ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: WPI ... Paul Bisaro, Watson,s President and Chief Executive Officer, will ... at the Barclay,s 2011 Global Healthcare Conference ... presentation will be webcast live and can be accessed ...
Cached Medicine Technology:Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company 2Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company 3
(Date:9/20/2014)... York, New York (PRWEB) September 20, 2014 ... power morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological ... that yet another insurer has announced plans to ... statement posted on its website last month, Harrisburg, ... procedures effective November 1, 2014. The insurer said ...
(Date:9/20/2014)... 2014 Recently, Best Cheap Hosting ... launched its new website. The new site provides ... hosting products for customers. Here, people can find ... purchasing decision. Also, it has recommended some excellent ... One of the great web hosting suppliers, InMotion ...
(Date:9/20/2014)... Traditionally dentists have advised their patients against drinking coffee ... is re-visiting that advice and changing his stance after considering ... have on oral health. “There’s good news and great news,” ... beneficial in protecting against gum disease, and red wine can ... was from the September 2014 issue of Boston University ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 Recently, UWDress.com, ... dresses and women’s special occasion outfits, has launched a ... The company’s prom outfits are popular among worldwide clients. ... get wholesale prom dresses on its website. ... for customers from around the world. Great custom made ...
(Date:9/20/2014)... New York, NY (PRWEB) September 20, 2014 ... million of their customers may have had their credit card ... late last year, spawning a slew of headline articles ... but those weren’t the only eye opening numbers. , ... numbers were stolen, almost like it’s a way to score ...
Breaking Medicine News(10 mins):Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5
... Healthcare Leaders With Information and,Best Practices Related ... WASHINGTON, April 17 The new ... that will eliminate or,reduce payments for three ... a two-day conference for healthcare executives and ...
... Projects show potential of computer science to profoundly impact prediction ... and treatment ... with the ability to predict and prevent adverse drug responses,within ... illnesses such as Parkinson,s disease and Alzheimer,s,disease, are just two ...
... In a move that will benefit children of ... premier childrens hospitals in the United States, and the ... have formalized a longtime relationship by officially becoming international ... sister cities, the formal linkage of hospitals in two ...
... Trust Inc.,(NYSE: CRE ) today announced it named ... Care,s Board of Directors, which increases the,number of members ... as President of Corporate Finance at CIT, Owens, 48, ... leaders,in assessing their go-to-market models, developing integrated distribution,platforms that ...
... 2008 Babies with an eye-alignment disorder called ... but development catches up after corrective surgery, reports ... (American Association for Pediatric Ophthalmology and Strabismus). , ... Retina Foundation of Southwest Texas, Dallas, the researchers ...
... Technology through ... ... Medical,Solutions USA Inc. (http://www.siemens.com/healthcare ) today announced a ... in numerous,strategic healthcare industry organizations., (Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ...
Cached Medicine News:Health News:APIC Conference to Address New CMS Regulations 2Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 2Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 3Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 4Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 5Health News:Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals 2Health News:Care Investment Trust Names Walter J. Owens to Board of Directors 2Health News:Infantile esotropia linked to developmental delays 2Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 2Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 3Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 4Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 5
ELISA kit for Varicella-zoster IgM....
... (VZV) IgG Enzyme-Linked Immunosorbent Assay (ELISA) is ... of IgG antibody to VZV in human ... used for the determination of immune status. ... used to demonstrate seroconversion or a significant ...
... The Zeus Scientific, Inc. Mumps IgG ELISA ... detection of Mumps IgG antibody in human ... the results of this test, together with ... determination of immune status, and/or aid in ...
... The Trinity Biotech Mumps IgM ... intended for the qualitative detection ... serum to Mumps for the ... performance characteristics of this kit ...
Medicine Products: